
Isoray ISR
Geschäftsbericht 2025
hinzugefügt 16.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Medizinische Instrumente |
Börse |
NYSE AMERICAN |
Anteile |
73.8 M |
Marktkapitalisierung |
$ 108 M |
EBITDA (LTM) |
$ -41.2 M |
P/E (LTM) |
- |
P/S (LTM) |
13.42 |
EPS (LTM) |
-1.03 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
AtriCure
ATRC
|
$ 28.66 | 1.52 % | $ 1.37 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 59.27 | 3.4 % | $ 2.98 B | NYSE,SPB | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 79.74 | 2.22 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 9.63 | 6.76 % | $ 23.4 M | Nasdaq Capital Market | ||
|
Repro Med Systems
KRMD
|
$ 4.34 | 3.09 % | $ 200 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 71.7 | 0.69 % | $ 14.3 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.35 | -9.27 % | $ 108 M | Nasdaq Global Select Market | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Harvard Bioscience
HBIO
|
$ 4.66 | 8.0 % | $ 207 M | Nasdaq Global Market | ||
|
electroCore
ECOR
|
$ 6.29 | 3.37 % | $ 53.4 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 26.91 | 1.97 % | $ 4.52 B | NYSE | ||
|
Masimo Corporation
MASI
|
$ 178.47 | 0.08 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 52.4 | 1.79 % | $ 172 M | Nasdaq Global Select Market | ||
|
iRhythm Technologies
IRTC
|
$ 120.45 | 4.52 % | $ 3.85 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 3.8 % | $ 23.8 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 70.57 | 3.38 % | $ 4.17 B | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 4.31 % | $ 21 M | NYSE American | ||
|
Glaukos Corporation
GKOS
|
$ 119.49 | 2.65 % | $ 5.79 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 129.32 | 2.9 % | $ 3.19 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.73 | 3.73 % | $ 201 M | NYSE American | ||
|
STERIS plc
STE
|
$ 224.85 | 1.03 % | $ 22.2 B | NYSE,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 123.18 | 4.05 % | $ 5.5 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 67.15 | 1.9 % | $ 218 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 458.96 | 1.85 % | $ 164 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 115.17 | 0.48 % | $ 2.61 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 12.02 | 2.65 % | $ 2.4 B | Nasdaq Global Select Market,SPB | ||
|
BioLife Solutions
BLFS
|
$ 20.11 | 1.87 % | $ 926 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 17.63 | 2.8 % | $ 9.04 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 230.26 | 0.61 % | $ 33.6 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 18.92 | 1.34 % | $ 1.28 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.92 | 2.67 % | $ 175 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.84 | 1.51 % | $ 1.33 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 259.96 | 1.33 % | $ 18.8 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 10.24 | 4.49 % | $ 418 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.43 | 0.78 % | $ 44.7 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.91 | -1.69 % | $ 30.2 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.08 | 4.05 % | $ 226 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 122.59 | 2.07 % | $ 6.83 M | Nasdaq Global Select Market,SPB |